Principal investigators and laboratory managers seeking to kopen follistatin peptide online for preclinical research must prioritize verified chemical purity, precise molecular mass identification, and stringent endotoxin controls. PX1 Research supplies high-purity, USA-manufactured Follistatin variants accompanied by lot-specific Certificates of Analysis for rigorous in vitro and animal model experimentation.
Principal investigators and laboratory managers seeking to kopen follistatin peptide online for preclinical research must prioritize verified chemical purity, precise molecular mass identification, and stringent endotoxin controls. PX1 Research supplies high-purity, USA-manufactured Follistatin variants accompanied by lot-specific Certificates of Analysis for rigorous in vitro and animal model experimentation.
To successfully procure research-grade peptide compounds online—often searched under regional procurement queries such as to kopen follistatin peptide online—researchers must establish stringent supplier vetting protocols. Follistatin is an autocrine glycoprotein that requires precise conformational folding and high purity standards to maintain structural fidelity in experimental assays.
When acquiring candidate compounds from the PX1 Research all peptides catalog, verified laboratories receive lot-specific documentation confirming chemical identity and sequence purity. Sourcing from domestic facilities operating under strict Quality Management Systems (QMS) ensures that analytical assays yield reproducible results free from synthesis-derived artifacts or biological contaminants.
Follistatin (FST) is a monomeric cysteine-rich glycoprotein encoded by the FST gene. Alternative splicing gives rise to distinct peptide isoforms, primarily Follistatin-344 (FST-344) and Follistatin-315 (FST-315), alongside C-terminally truncated derivatives such as Follistatin-288 (FST-288).
In recombinant research settings, follistatin 344 acts as a precursor that undergoes post-translational cleavage to yield the functional tissue-binding isoforms. The molecular architecture features three domain repeats (FS1, FS2, and FS3) that mediate high-affinity neutralisation of specific members of the Transforming Growth Factor-beta (TGF-β) superfamily. Understanding isoform-specific cell surface heparin-binding properties is critical when selecting reagents for localized versus systemic preclinical assays.
The principal biochemical pathway of Follistatin involves bivalent binding to Activin A and Myostatin (Growth Differentiation Factor 8, or GDF-8). Preclinical studies suggest that Follistatin sequesters these ligands, preventing their interaction with Activin type II receptors (ActRIIA and ActRIIB) on target cell membranes.
By preventing ligand-receptor engagement, Follistatin inhibits downstream Smad2/3 phosphorylation and subsequent transcriptional activation of gene networks that restrict skeletal muscle differentiation. In vitro cell culture models demonstrate that blockade of this signaling cascade allows myoblast proliferation and fusion without activating classical hypertrophic intracellular cascades directly, distinguishing it from standard receptor agonists.
In vivo rodent models evaluating myostatin inhibition frequently utilize Follistatin gene delivery or recombinant peptide administration to investigate muscular dystrophy, sarcopenia, and metabolic homeostasis. Observations published in muscle biology literature show marked increases in wet tissue mass and cross-sectional myofiber area following continuous ligand blockade.
Furthermore, preclinical research indicates that Follistatin plays functional roles beyond skeletal muscle tissue. In vitro investigations into reproductive endocrinology, hepatic glucose regulation, and adipose tissue browning highlight the complex systemic crosstalk mediated by Activin-Follistatin stoichiometry. Researchers investigating broader cellular metabolic targets can review cross-referenced studies in our research hub.
Within functional musculoskeletal research, Follistatin operates via distinct pathway mechanics compared to upstream endocrine modulators. While Follistatin directly neutralizes negative regulatory growth factors like Myostatin and Activin A, peptides such as IGF-1 LR3 stimulate myogenesis through direct activation of the Receptor Tyrosine Kinase (RTK) and Akt/mTOR signaling axis. Similarly, secretagogues like CJC-1295 no DAC modulate pulsatile growth hormone secretion upstream.
Evaluating these distinct pathways in tandem allows investigators to differentiate between ligand-neutralization cascades and receptor-driven anabolic signaling. Detailed mechanistic breakdowns comparing these peptide classes are documented in our myostatin inhibitors in research comparative guide.
Purchasing raw materials online introduces significant risks regarding batch variability, sequence misidentification, or bacterial contamination. PX1 Research mitigates these risks by subjecting every production lot to comprehensive analytical validation at accredited domestic testing facilities.
Purity is verified using Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring a baseline purity profile of ≥98%. Chemical structure and exact molecular weight are confirmed using Electrospray Ionization Mass Spectrometry (ESI-MS). Furthermore, because bacterial lipopolysaccharides can induce inflammatory responses in cell culture models, endotoxin levels are verified via Chromogenic LAL testing to remain strictly below 0.1 EU/mg.
Reconstitution of lyophilized Follistatin must be conducted under aseptic conditions within a certified laminar flow hood to prevent environmental contamination. Researchers should use sterile, non-pyrogenic Bacteriostatic Water or sterile phosphate-buffered saline (PBS, pH 7.4) depending on downstream assay specifications.
Lyophilized vials should be brought to room temperature prior to reconstitution to avoid condensation within the vial. Gently introduce the diluent along the glass wall and swirl slowly—never vortex violently—to prevent shear stress and peptide denaturation. Reconstituted stock solutions should be aliquoted into single-use polypropylene microtubes to avoid repeated freeze-thaw cycles that compromise tertiary protein structure.
Desiccated, lyophilized Follistatin remains stable at -20°C for up to 24 months from the date of manufacture. For long-term storage exceeding two years, maintaining stock at -80°C is recommended.
Once reconstituted into aqueous solution, aliquots should be stored at -20°C or -80°C for short-term and extended experimentation, respectively. Reconstituted solutions maintained at 2–8°C should be utilized within 48 to 72 hours. Avoid non-frost-free freezers, as temperature fluctuations during defrost cycles accelerate chemical degradation and hydrolysis.
All products provided by PX1 Research are intended strictly for in vitro laboratory research and preclinical animal experimentation. They are not cleared for human consumption, clinical diagnostic procedures, or veterinary therapeutic applications.
Principal investigators and laboratory managers looking to establish institutional supply lines can register for dedicated wholesale accounts. Orders placed prior to daily cutoff times ship same-day from our fulfillment facilities located in California and Arizona, complete with lot-matched analytical certificates.
What analytical documentation accompanies Follistatin orders from PX1 Research?
Every lot is supplied with a comprehensive, third-party Certificate of Analysis (COA) containing raw RP-HPLC chromatograms for purity verification, ESI-MS spectra for molecular mass confirmation, and LAL chromogenic endotoxin assay data.
What is the recommended reconstitution solvent for Follistatin in cell culture assays?
Sterile phosphate-buffered saline (PBS, pH 7.4) or sterile 0.9% sodium chloride is typically recommended for in vitro cellular protocols, while Bacteriostatic Water is preferred for multi-use stock solutions where secondary microbicidal protection is required.
How does Follistatin differ structurally from Myostatin Propeptide?
Follistatin is a naturally occurring endogenous binding protein that neutralizes both Myostatin and Activin A. In contrast, Myostatin Propeptide is a fragment derived specifically from the cleavage of the myostatin precursor protein, functioning solely as a targeted myostatin inhibitor.
What endotoxin thresholds are guaranteed for PX1 Research peptides?
PX1 Research enforces strict quality thresholds ensuring endotoxin content remains below 0.1 EU/mg, preventing endotoxin-induced cellular toxicity or unexpected immune activation during sensitive research assays.
Where are PX1 Research products manufactured and shipped from?
All peptides are manufactured in US-based, GMP-compliant facilities and dispatched directly from primary distribution nodes in California and Arizona.
Can Follistatin solutions undergo multiple freeze-thaw cycles?
No. Repeated freezing and thawing causes physical shear forces that disrupt protein folding and lead to aggregation. Stock solutions should be aliquoted into single-use volumes immediately after reconstitution.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.